Codes / ICD10CM / S20.324S

S20.324S Blister (nonthermal) of middle front wall of thorax, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Blister (nonthermal) of middle front wall of thorax, sequela

Summary

A blister (nonthermal) of the middle front wall of the thorax, sequela, refers to a residual or chronic condition resulting from a previous nonthermal blister injury to the middle front chest wall. This sequela involves persistent skin changes, such as scarring, discoloration, or altered texture, that remain after the initial blister has healed. It is a long-term consequence of the original injury and may require ongoing monitoring or management.

Causes

The sequela arises from a prior nonthermal blister injury to the middle front wall of the thorax, which could have been caused by friction, pressure, minor trauma, or contact with irritants. The original injury led to fluid accumulation beneath the skin, and the subsequent healing process resulted in permanent changes to the affected area.

Risk Factors

  • Previous nonthermal blister injury to the middle front wall of the thorax.
  • Delayed or inadequate treatment of the initial blister, increasing the risk of scarring.
  • Underlying skin conditions that impair healing, such as diabetes or poor circulation.
  • Repeated trauma to the same area, which may worsen residual skin changes.

Symptoms

  • Persistent discoloration (e.g., hyperpigmentation or hypopigmentation) of the middle front chest wall.
  • Scarring or thickening of the skin at the site of the original blister.
  • Altered skin texture, such as roughness or induration.
  • Possible mild tenderness or sensitivity in the affected area.

Diagnosis

Physical examination of the middle front wall of the thorax to assess residual skin changes, including scarring, discoloration, or texture alterations. Review of the patient’s medical history to confirm a prior nonthermal blister injury to the same area. Observation for signs of ongoing inflammation or complications that may require further evaluation.

Treatment Options

Management focuses on addressing symptoms and preventing further skin damage. This may include topical treatments to improve skin texture or reduce discoloration, such as moisturizers or silicone-based scar creams. In some cases, procedures like laser therapy or microdermabrasion may be considered to minimize scarring. Protective measures, such as avoiding friction or irritation to the area, are also recommended.

Prognosis and Follow-Up

The prognosis is generally favorable, with most sequela remaining stable over time. However, the extent of residual changes depends on the severity of the initial injury and individual healing factors. Regular follow-up may be advised to monitor for any worsening of symptoms or new complications, such as infection or chronic pain.

Complications

  • Chronic pain or discomfort in the affected area.
  • Increased susceptibility to recurrent injury due to altered skin integrity.
  • Psychological impact from visible scarring or discoloration.
  • Rarely, infection if the sequela involves open or irritated skin.

Lifestyle & Prevention

  • Avoid activities that may cause friction or pressure on the middle front chest wall.
  • Use protective clothing or padding in high-risk environments.
  • Maintain good skin hygiene to support overall skin health.
  • Seek prompt treatment for any new injuries to the area to minimize long-term effects.

When to Seek Professional Help

Consult a healthcare provider if the sequela causes significant pain, shows signs of infection (e.g., redness, swelling, pus), or worsens over time. Additionally, seek care if new blisters or skin changes develop in the same area, as this may indicate a recurrent issue or underlying condition.

Tips for Medical Coders

This code is used for a sequela (late effect) of a nonthermal blister injury specifically to the middle front wall of the thorax. Documentation should clearly indicate the prior injury and the residual effects, such as scarring or discoloration, to support the sequela diagnosis. Ensure the code aligns with the patient’s medical history and current clinical findings.

Book a walkthrough

S20.324S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.